Cutaneous Squamous Cell Carcinoma in Situ (CSCCis) Completed Phase 1 / 2 Trials for Cotsiranib (DB18404)

Also known as: Bowen Disease / Bowens Disease / Cutaneous Squamous Cell Carcinoma in Situ / Squamous Cell Carcinoma in Situ / Bowen's Disease / Squamous cell carcinoma in situ (morphologic abnormality) / Squamous intraepithelial neoplasia, grade III (morphologic abnormality) / Intra-epidermal carcinoma / Intraepithelial squamous cell carcinoma (disorder) / Intraepidermal carcinoma / Bowen's disease (morphologic abnormality) / Squamous cell carcinoma in situ of skin (disorder) / Planocellular carcinoma / Squamous cell carcinoma (morphologic abnormality) / Squamous cell carcinoma (disorder) / Epidermoid carcinoma / Carcinoma, Squamous Cell / Squamous cell carcinoma / Carcinoma epidermoid / Carcinoma squamous

IndicationStatusPhase
DBCOND0092857 (Cutaneous Squamous Cell Carcinoma in Situ (CSCCis))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04293679
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCCTreatment